期刊文献+

非诺贝特缓释微球片体内外相关性评价 被引量:10

Evaluation of in vitro-in vivo correlation of fenofibrate sustained-release microspheres tablets
下载PDF
导出
摘要 目的:用脱卷积法进行自制非诺贝特缓释微球片体内外相关性的评价。方法:以市售微粒化非诺贝特胶囊剂的大鼠体内血药浓度数据为权函数,根据自制非诺贝特缓释微球片制剂大鼠体内血药浓度数据,采用脱卷积法,将不同时间点的体内吸收分数与体外累计释放百分数做线性回归,考察体内外相关性。结果:采用脱卷积法计算体外累计释放百分数和体内吸收分数相关系数较好(r=0.9225),相关性方程为Y=0.4642R+42.044。结论:脱卷积法适用于非诺贝特缓释微球片的体内外相关性研究。 OBJECTIVE To evaluate the in vitro-in vivo correlation of self-designed tablets of fenofibrate sustained-release microspheres using deconvolution method. METHODS The characteristics of in vivo release were calculated by deconvolation method using the data of plasma concentration of self-designed sustained-release fenofibrate formulation in rats,in which the in vivo results of micronized fenofibrate capsule solution after oral administrated to rats were used as weight function. The in vitro-in vivo correlation was screened by comparing the linear regressive equations between the absorption percentage in vivo and the accumulate dissolution percentage in vitro. RESULTS The good correlation coefficient(r= 0. 922 5) could be abtained between the absorption percentage in vivo and accumulation dissolution percentage in vitro by deconvolution method, the equation was Y = 0. 464 2R + 42. 044. CONCLUSION The deconvolution method exhibits advantage in evaluation of in vitro-in vivo correlation for tablets of fenofibrate sustained-release microspheres.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2008年第12期975-978,共4页 Chinese Journal of Hospital Pharmacy
关键词 非诺贝特 缓释微球片 脱卷积法 体内外相关性 fenofibrate tablets of sustained-release microspheres deconvolution method in vivo and in vitro correlation
  • 相关文献

参考文献4

二级参考文献7

  • 1郑颉,药物分析杂志,1988年,8卷,2期,89页 被引量:1
  • 2Balan G, Timmins P, Greene DS, et al. In vitro-in vivo correlation models for metformin after administration of modified-release oral dosage forms to healthy human volunteers [ J]. J Pharm Sci, 2001,90(8): 1176 - 1185. 被引量:1
  • 3Krol GJ, Lettieri JT, Yeh SC, et al. Disposition and pharmacokinetics of 14C-nitrendipine in healthy volunteers [J]. J Cardiovasc Pharmacol, 1987,9(Suppl 4) :S122-S128. 被引量:1
  • 4Langenbucher F, Mysicka J. In vitro and in vivo deconvolution assessment of drug release kinetics from oxprenolol oros preparations [J]. Br J Clin Pharmacol,1985,19:151S - 162S. 被引量:1
  • 5Wagner JG. Do you need a pharmacokinetic method, and if so, which one? [J] J Pharmacokin Biopharm, 1975,3(6) :457-478. 被引量:1
  • 6Vaughan DP, Nennis M. Mathematical basis of pointarea deconvolution method for determining in vivo input functions [J]. J Pharm Sci, 1978,67(5) :663 -665. 被引量:1
  • 7谢永新,岑路.气相色谱法测定降血脂药非诺贝特的含量[J].西北药学杂志,1990,5(2):11-12. 被引量:1

共引文献26

同被引文献104

引证文献10

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部